Showing results (111-120 of 160) with videos related to

Sort By:
Pageof 16
Oncotarget|April 22, 2017
Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutationsStefano Frega, Martina Lorenzi, Matteo Fassan, et al.
Cancer Cell|October 7, 2008
Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasisMichele De Palma, Roberta Mazzieri, Letterio S Politi, et al.
Cancers|April 14, 2025
Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept StudyElisa Pinto, Elisabetta Lazzarini, Filippo Pelizzaro, et al.
Frontiers in Oncology|March 29, 2021
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA AnalysisLoredana Urso, Grazia Vernaci, Jessica Carlet, et al.
Trials|August 4, 2025
Regorafenib versus local standard of care in patients with grade 2-3 meningioma no longer eligible for loco-regional treatments: a phase II randomized controlled trial (the MIRAGE study)Alberto Bosio, Giulia Cerretti, Marta Padovan, et al.
Biology|April 30, 2021
Low P66shc with High SerpinB3 Levels Favors Necroptosis and Better Survival in Hepatocellular CarcinomaSilvano Fasolato, Mariagrazia Ruvoletto, Giorgia Nardo, et al.
Haematologica|August 31, 2019
Dissecting molecular mechanisms of resistance to NOTCH1-targeted therapy in T-cell acute lymphoblastic leukemia xenograftsValentina Agnusdei, Sonia Minuzzo, Marica Pinazza, et al.
Blood|April 20, 2021
A novel and highly effective mitochondrial uncoupling drug in T-cell leukemiaVictoria da Silva-Diz, Bin Cao, Olga Lancho, et al.
British Journal of Cancer|May 8, 2020
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancerElisabetta Zulato, Ilaria Attili, Alberto Pavan, et al.
British Journal of Pharmacology|April 26, 2021
BBIT20 inhibits homologous DNA repair with disruption of the BRCA1-BARD1 interaction in breast and ovarian cancerLiliana Raimundo, Angela Paterna, Juliana Calheiros, et al.
Pageof 16